-
EntrepreneurGreentech Laboratories ADVANCING HUMAN LIFE WITH TECHNOLOGIES FOR INNER WELLBEING
-
EntrepreneurKurve Therapeutics The Future of Systemic and Central Nervous System (CNS) Therapies - Bringing solutions to clinical unmet needs
-
EntrepreneurMedAware Transforming patient safety
-
EntrepreneurGel Dynamics A Vetted Solution With A Global Market
-
EntrepreneurAddimmune Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
-
EntrepreneurTracFlo A vertical SaaS Fintech focused on construction
-
EntrepreneurCommerceBlitz Optimizing Inventory and Distribution Operations for eCommerce Businesses
-
EntrepreneurAdlore Introducing SenLore - A Novel Device to Treat and Monitor Diabetic Foot Ulcers
-
EntrepreneurCreative BioTherapeutics WE START WHERE OTHER THERAPIES FAIL FOR RECURRENT & DRUG RESISTANT CANCERS
-
EntrepreneurTitin KM Biomedical Corporation THE FUTURE OF SHOULDER REHABILITATION
-
InformationiCFO Information Booth How can we help?
-
EntrepreneurPROOF Hard Ice Cream PROOF will be among the most highly recommended gourmet brands in the world
-
EntrepreneurNob Hill Therapeutics Pioneering Respiratory Patient Care
Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Calvin Goforth!
Join us next time to meet Calvin Goforth!
About VIC Tech
VIC Tech
A LIFE SCIENCE VENTURE STUDIO - Building a Healthy Future
Available from
12:00 PM
-
4:00 PM
(US/Pacific)
VIC Tech is a life science venture studio that sources innovative life science technologies from top research institutions around the world, systematically vets the technologies and selects the ones with the highest impact and commercial potential to be exclusively licensed into startup companies that VIC forms and builds. VIC puts in place the initial team including experienced management and talented product development teams as well as the founding capital through it’s affiliated VIC Investor Network. VIC Tech’s current portfolio of life science companies have raised in excess of $350M and have brought high-impact innovation from the research lab to the commercial market.